SUN-LB015 Baseline Characteristics and Effects on CV and Kidney Outcomes with Linagliptin Versus Placebo, Across GFR Categories in CARMELINA

People with type 2 diabetes (T2D) with concomitant chronic kidney disease (CKD) and cardiovascular (CV) disease are at increased risk for recurrent CV events and hypoglycemia. Treatment of these individuals is clinically challenging, where the evidence-base for safety and efficacy of glucose lowerin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahn, Steven, Perkovic, Vlado, Johansen, Odd Erik, Rosenstock, Julio, McGuire, Darren, Toto, Robert, Nikolaus, Marx, Alexander, John, Zinman, Bernard, Pfarr, Egon, Schnaidt, Sven, Meinicke, Thomas, George, Jyothis, von Eynatten, Max, Cooper, Mark, Wanner, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553362/
http://dx.doi.org/10.1210/js.2019-SUN-LB015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553362/
http://dx.doi.org/10.1210/js.2019-SUN-LB015

Ejemplares similares